Remove 2008 Remove Consumption Remove Safety Remove Terpenes
article thumbnail

Best strains and terpenes for migraine relief

The Cannigma

Based on the limited existing evidence, the best cannabis strain for migraines may be a Type II that includes both THC and CBD, and a terpene profile that includes beta-caryophyllene, myrcene, linalool, limonene, bisabolol, humulene or pinene. The study called out pinene, myrcene, and beta-caryophyllene as specifically useful terpenes.

Terpenes 132
article thumbnail

Doctor Block…….”A Physician Botanist’s Insight to Cannabis species: The Naming of Plants and Products”

TheAnswerPage

Hemp is a Cannabis crop typically grown for seed and fiber production that more recently has been incorporated into the industrial manufacture of several derived products, including biodegradable plastics, biofuel, clothing, textiles, insulation, paper, food, and food for animal consumption. Retrieved 2008-06-20. Extreme Chemistries.

Sativa 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ElleVet Sciences Publishes Safety Study On CBD For Animals

Cannabis Law Report

ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., Dr. Wakshlag is currently available for interviews to discuss the results of the safety study as well as his clinical trials.

Safety 45
article thumbnail

What is THC? Here’s everything you need to know

The Cannigma

The safety of using these products however, is still unknown. Here are some factors that can influence your experience: other cannabinoids and terpenes the consumption method you prefer your own unique biological makeup. Being an extremely safe drug doesn’t mean there are no risks associated with cannabis consumption.

THC 98
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. 2018 ; Frankhauser 2008 ). At the same time, the outlook on cannabis research data is largely positive.